A 48-week Phase 2 trial reported in The Lancet in 2025 showed mean weight reduction ranging from approximately 9% at the lowest dose to 20% at the highest dose, compared with 0.4% on placebo

Heres some information to help you and your healthcare provider make responsible decisions for your long-term health: Who should avoid GLP-1 medications GLP-1 medications like semaglutide and liraglutide may not be right for you if any of the following conditions apply: You are allergic or hypersensitive to GLP-1 receptor agonists You are pregnant or planning to become pregnant You have severe gastroparesis or inflammatory bowel disease You have a personal or family history of specific thyroid conditions, including multiple endocrine neoplasia (2A or 2B) or medullary thyroid cancer , You have had pancreatitis or develop it while on these drugs You are taking other semaglutide medications Boxed Warning : Risk of Thyroid C-Cell Tumors GLP-1 medications have been linked to a risk of thyroid C-cell tumors based on animal studies

[#4/8] consider pyridoxine indications for pyridoxine in status epilepticus [1] Possible pyridoxine deficiency : [2] Levetiracetam : Pyridoxine administration may also help reduce behavioral side effects
But its not only those who follow a vegetarian or vegan diet who may be at risk of a vitamin D deficiency
, 5 , 45-66, Islam, K., Chen, Y., Wu, H., Bothwell, I
Iliopoulos, D., Hirsch, H